(Q50205579)

27 February 2018

title

A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children. (English)

1 reference

27 February 2018

1 reference

1 reference

1 reference

1 reference

Jacobs RF

1

1 reference

27 February 2018

Wells TG

series ordinal

2

1 reference

27 February 2018

Steele RW

series ordinal

3

1 reference

27 February 2018

Yamauchi T

series ordinal

4

1 reference

27 February 2018

language of work or name

English

0 references

publication date

1 July 1985

1 reference

27 February 2018

The Journal of Pediatrics

published in

1 reference

27 February 2018

volume

107

1 reference

27 February 2018

page(s)

129-133

1 reference

27 February 2018

issue

1

1 reference

27 February 2018

Intravenous cefotaxime in children with bacterial meningitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

Cefotaxime in the treatment of severe paediatric infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

Cefotaxime therapy of serious bacterial infection in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

Activity of HR 756 against Haemophilus influenzae, Barteroides fragilis and Gram-negative rods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

Cefotaxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

The comparative .BETA.-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

Pharmacokinetics and Bacteriologic Efficacy of Moxalactam, Cefotaxime, Cefoperazone, and Rocephin in Experimental Bacterial Meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

Beta-lactam antibiotic susceptibility of bacteria responsible for neonatal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

Salmonella meningitis. A report of three cases and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

A comparison of ampicillin-cefotaxime and ampicillin-chloramphenicol in childhood bacterial meningitis: an experience in 55 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980634-X

10.1016/S0022-3476(85)80634-X

7 January 2021

Identifiers

DOI

1 reference

27 February 2018

PubMed ID

3847486

1 reference

27 February 2018